Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 23 February

Bell Direct
February 23, 2024

Morning Bell 22 February

Bell Direct
February 22, 2024

Morning Bell 21 February

Bell Direct
February 21, 2024

Morning Bell 20 February

Bell Direct
February 20, 2024

Morning Bell 19 February

Bell Direct
February 19, 2024

Weekly Wrap 16 February

Bell Direct
February 16, 2024

Morning Bell 16 February

Bell Direct
February 16, 2024

Morning Bell 15 February

Bell Direct
February 15, 2024

Morning Bell 14 February

Bell Direct
February 14, 2024

Morning Bell 13 February

Bell Direct
February 13, 2024

Morning Bell 12 February

Bell Direct
February 12, 2024